Close Menu

NEW YORK – November was a mixed month for the stocks of many diagnostics firms as the 360Dx Index rose about 1 percent from October.

Of the 32 companies in the Index, seven firms saw their share prices drop last month paced by Quidel (-27 percent) and Accelerate Diagnostics (-17 percent). Meanwhile, 25 companies' stock prices rose, led by Veracyte (+57 percent), Quotient Limited (+47 percent), and Myriad Genetics (+41 percent).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.